Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes.
about
A Complex Interplay between Wnt/β-Catenin Signalling and the Cell Cycle in the Adult LiverMonitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells.c-Myc and transforming growth factor α enhance the development of hepatic lesions due to mutant β-catenin in transgenic miceBeta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.Mutant Hras(G12V) and Kras(G12D) have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic miceChemically induced mouse liver tumors are resistant to treatment with atorvastatin.Effect of allyl alcohol on hepatic transporter expression: zonal patterns of expression and role of Kupffer cell functionRecent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology.Mechanisms of RAS/β-catenin interactions.Signal integration by the CYP1A1 promoter--a quantitative studyPre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems.The nuclear factor κB inhibitor (E)-2-fluoro-4'-methoxystilbene inhibits firefly luciferase.Genetic ablation of β-catenin inhibits the proliferative phenotype of mouse liver adenomas.Transplantation of Gene-Edited Hepatocyte-like Cells Modestly Improves Survival of Arginase-1-Deficient Mice.
P2860
Q21284963-ED7EFBE0-FCFB-4BCD-BA5E-117E6372E228Q27311697-79C3995C-4129-4AA7-ACDF-A05B63B9BC4CQ34539365-2F2DC260-26F8-4D2D-8DF1-0915D98B79A4Q34630557-9A81872C-1B40-47A8-95EC-E1CD336580EDQ35057068-511ECD27-33B7-49AE-8BAE-E94F2393370CQ35335391-15D2BA26-B2EB-4669-94BD-A74F4C3F3783Q35496210-3B258B19-7BD6-4E72-83D0-D893789C5D53Q37121662-491D7A17-8427-4FD9-85B4-55CCA687D675Q37298654-68B15709-B1A0-4D8B-A5D4-DD97B1CDB2A9Q38088654-2053340B-0A18-4EDD-BDAF-31C6A837145AQ38879910-1F6E4734-8F20-4783-A0DD-2C2A4F7BB88AQ39280379-2E460E42-523D-401D-8AF5-54F7AA22DAD3Q39315817-39F0CE36-5C1C-4BE5-9D60-F3F9EFA87A7EQ41870215-34ABE141-CACF-479D-A3E5-336A8016B3BBQ55407383-44D505AD-0E8D-43A7-846F-736FA4530BDB
P2860
Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Serum components and activated ...... ignaling in mouse hepatocytes.
@en
type
label
Serum components and activated ...... ignaling in mouse hepatocytes.
@en
prefLabel
Serum components and activated ...... ignaling in mouse hepatocytes.
@en
P2093
P2860
P1433
P1476
Serum components and activated ...... ignaling in mouse hepatocytes.
@en
P2093
Albert Braeuning
Albrecht Buchmann
Christoph Köhle
Eva-Maria Kleinschnitz
Michael Schwarz
Moritz Menzel
Naomoto Harada
Yoshitaka Tamai
P2860
P304
P356
10.1111/J.1742-4658.2007.06002.X
P407
P577
2007-08-14T00:00:00Z